申请人:Eisai R&D Management Co., Ltd.
公开号:EP1757591A1
公开(公告)日:2007-02-28
The present invention relates to a compound represented by Formula (I):
(wherein Ar1 represents an imidazolyl group which may be substituted with 1 to 3 substituents; Ar2 represents a pyridinyl group, a pyrimidinyl group, or a phenyl group which may be substituted with 1 to 3 substituents; X1 represents (1) -C≡C- or (2) a double bond etc. which may be substituted; R1 and R2 represent, for example, a C1-6 alkyl group or C3-8 cycloalkyl group which may be substituted) or a pharmacologically acceptable salt thereof and to the use thereof as pharmaceutical agents.
本发明涉及一种由式(I)表示的化合物:
(其中Ar1代表可被1至3个取代基取代的咪唑基;Ar2代表可被1至3个取代基取代的吡啶基、嘧啶基或苯基;X1代表(1)-C≡C-或(2)可被取代的双键等;R1和R2代表例如可被取代的C1-6烷基或C3-8环烷基)或其药理学上可接受的盐,以及其作为药剂的用途。